Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd

Hiddo Lambers Heerspink; David C. Wheeler; Niels Jong; Ricardo Correa-Rotter; Peter Rossing; Ronald Gansevoort; John Mcmurray; Anna Maria Langkilde; Robert Toto; Glenn Chertow

doi:10.1093/ndt/gfad063a_3382

Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd

Hiddo Lambers Heerspink, David C. Wheeler, Niels Jong, Ricardo Correa-Rotter, Peter Rossing, Ronald Gansevoort, John Mcmurray, Anna Maria Langkilde, Robert Toto, Glenn Chertow

Steno Diabetes Center Copenhagen

Original language	English
Article number	#3382
Journal	Nephrology Dialysis Transplantation
Volume	38
Issue number	1
Pages (from-to)	i52-i53
ISSN	0931-0509
DOIs	https://doi.org/10.1093/ndt/gfad063a_3382
Publication status	Published - 1 Jun 2023
Event	ERA Congress 2023 - Milan, Italy Duration: 15 Jun 2023 → 18 Jun 2023 Conference number: 60 https://www.era-online.org/events/milan-2023/

Conference

Conference	ERA Congress 2023
Number	60
Country/Territory	Italy
City	Milan
Period	15/06/2023 → 18/06/2023
Internet address	https://www.era-online.org/events/milan-2023/

Access to Document

10.1093/ndt/gfad063a_3382

Cite this

Heerspink, H. L., Wheeler, D. C., Jong, N., Correa-Rotter, R., Rossing, P., Gansevoort, R., Mcmurray, J., Langkilde, A. M., Toto, R., & Chertow, G. (2023). Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd. Nephrology Dialysis Transplantation, 38(1), i52-i53. Article #3382. https://doi.org/10.1093/ndt/gfad063a_3382

Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd. / Heerspink, Hiddo Lambers; Wheeler, David C.; Jong, Niels et al.
In: Nephrology Dialysis Transplantation, Vol. 38, No. 1, #3382, 01.06.2023, p. i52-i53.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Heerspink, HL, Wheeler, DC, Jong, N, Correa-Rotter, R, Rossing, P, Gansevoort, R, Mcmurray, J, Langkilde, AM, Toto, R & Chertow, G 2023, 'Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd', Nephrology Dialysis Transplantation, vol. 38, no. 1, #3382, pp. i52-i53. https://doi.org/10.1093/ndt/gfad063a_3382

@article{9aedf7e901e541a285315d50698ded08,

title = "Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd",

author = "Heerspink, {Hiddo Lambers} and Wheeler, {David C.} and Niels Jong and Ricardo Correa-Rotter and Peter Rossing and Ronald Gansevoort and John Mcmurray and Langkilde, {Anna Maria} and Robert Toto and Glenn Chertow",

note = "60th ERA Congress, Milan, ITALY, JUN 15-18, 2023; ERA Congress 2023, ERA 2023 ; Conference date: 15-06-2023 Through 18-06-2023",

year = "2023",

month = jun,

day = "1",

doi = "10.1093/ndt/gfad063a_3382",

language = "English",

volume = "38",

pages = "i52--i53",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "OXFORD UNIV PRESS",

number = "1",

url = "https://www.era-online.org/events/milan-2023/",

}

TY - ABST

T1 - Reasons for dialysis initiation and safety of dapagliflozin among dialysis participants: new insights from dapa-ckd

AU - Heerspink, Hiddo Lambers

AU - Wheeler, David C.

AU - Jong, Niels

AU - Correa-Rotter, Ricardo

AU - Rossing, Peter

AU - Gansevoort, Ronald

AU - Mcmurray, John

AU - Langkilde, Anna Maria

AU - Toto, Robert

AU - Chertow, Glenn

N1 - Conference code: 60

PY - 2023/6/1

Y1 - 2023/6/1

U2 - 10.1093/ndt/gfad063a_3382

DO - 10.1093/ndt/gfad063a_3382

M3 - Conference abstract in journal

SN - 0931-0509

VL - 38

SP - i52-i53

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

IS - 1

M1 - #3382

T2 - ERA Congress 2023

Y2 - 15 June 2023 through 18 June 2023

ER -